HEB Financial Facts

Basic and diluted loss per share (Note 2): -0.02
Production/cost of goods sold: 191K
See Full Income Statement

Property and equipment, net: 5.13M
Total current assets: 38.58M
See Full Balance Sheet

Earnings History for Hemispherx Biopharma, Inc. (HEB)

  |   Expand Research on HEB
Next EPS Date 3/14/13 *Est. EPS Growth Rate N/A
Average EPS % Beat Rate N/A Revenue Growth Rate N/A
Average % Move 1-Wk after EPS N/A    
Date  Qtr EPS Cons. Surprise Revs Cons. Estimize EPS/Revs Gd. % Since Details
11/5/12 Q312 -$0.04N/A N/A N/AN/A N/A / N/A N/A 0% Details
8/9/12 Q212 -$0.02N/A N/A N/AN/A N/A / N/A N/A 0% Details
5/7/12 Q112 -$0.02N/A N/A N/AN/A N/A / N/A N/A 0% Details
3/14/12 Q411 -$0.02N/A N/A $38KN/A N/A / N/A N/A 0% Details
Like HEB Earnings? Also take a look at NVAX, SVA, BCRX, ZNGA

HEB Earnings News